Skip to main content
HR 1334 103th Congress House Health Administrative procedure Biological research Commercialization Department of Health and Human Services Drugs Federal aid to medical research Federal aid to research Government and business Medical economics Medical research Medical supplies Pharmaceutical research Prescription pricing Research and development contracts Research grants

Federal Research Product Commercialization Act

Introduced: March 11, 1993 Introduced by: Wyden, Ron Democratic · Oregon See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 23, 1993
Sponsor introductory remarks on measure. (CR H5049-5050)
Mar 29, 1993
Referred to the Subcommittee on Health and the Environment.
Mar 11, 1993
Referred to the House Committee on Energy and Commerce.
Mar 11, 1993
Sponsor introductory remarks on measure. (CR E612-613)
Mar 11, 1993
Introduced in House
 Plain-English summary Congressional Research Service

Federal Research Product Commercialization Act - Amends the Public Health Service Act to require that a biomedical research project relating to the development of a drug, device, or other tangible product may not be supported by the National Institutes of Health (NIH) unless there is in effect an agreement ensuring that any commercial parties involved in the project make the product available to the public at a reasonable price and that the commercial parties pay NIH royalties reasonably related to the amounts NIH spent with respect to the product.

What's happening now July 23, 1993

Sponsor introductory remarks on measure. (CR H5049-5050)

 Committees of jurisdiction 2